BRPI0817835A2 - Antagonistas cgrp - Google Patents
Antagonistas cgrpInfo
- Publication number
- BRPI0817835A2 BRPI0817835A2 BRPI0817835A BRPI0817835A2 BR PI0817835 A2 BRPI0817835 A2 BR PI0817835A2 BR PI0817835 A BRPI0817835 A BR PI0817835A BR PI0817835 A2 BRPI0817835 A2 BR PI0817835A2
- Authority
- BR
- Brazil
- Prior art keywords
- cgrp antagonists
- cgrp
- antagonists
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/10—Spiro-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/10—Spiro-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
- C07D498/20—Spiro-condensed systems
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Pain & Pain Management (AREA)
- Diabetes (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Reproductive Health (AREA)
- Endocrinology (AREA)
- Neurology (AREA)
- Cardiology (AREA)
- Gynecology & Obstetrics (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Immunology (AREA)
- Rheumatology (AREA)
- Dermatology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pregnancy & Childbirth (AREA)
- Emergency Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP07118811 | 2007-10-18 | ||
| PCT/EP2008/063967 WO2009050234A1 (de) | 2007-10-18 | 2008-10-16 | Cgrp-antagonisten |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BRPI0817835A2 true BRPI0817835A2 (pt) | 2015-03-31 |
Family
ID=39047647
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0817835 BRPI0817835A2 (pt) | 2007-10-18 | 2008-10-16 | Antagonistas cgrp |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US8450327B2 (pt) |
| EP (2) | EP2386558B1 (pt) |
| JP (1) | JP5366960B2 (pt) |
| KR (1) | KR20100091972A (pt) |
| CN (1) | CN101827845A (pt) |
| AU (1) | AU2008313733A1 (pt) |
| BR (1) | BRPI0817835A2 (pt) |
| CA (1) | CA2702503A1 (pt) |
| CO (1) | CO6270226A2 (pt) |
| EA (1) | EA201000612A1 (pt) |
| EC (1) | ECSP10010105A (pt) |
| IL (1) | IL204928A0 (pt) |
| MA (1) | MA31782B1 (pt) |
| MX (1) | MX2010003849A (pt) |
| NZ (1) | NZ585347A (pt) |
| TN (1) | TN2010000173A1 (pt) |
| WO (1) | WO2009050234A1 (pt) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2009050234A1 (de) | 2007-10-18 | 2009-04-23 | Boehringer Ingelheim International Gmbh | Cgrp-antagonisten |
| EP2065381A1 (de) * | 2007-10-18 | 2009-06-03 | Boehringer Ingelheim Pharma GmbH & Co. KG | CGRP Antagonisten |
| EP2225223B1 (de) * | 2007-11-22 | 2017-01-11 | Boehringer Ingelheim International GmbH | Organische verbindungen |
| CN102791692B (zh) * | 2010-03-12 | 2015-05-27 | 日本曹达株式会社 | 叔丁氧基羰基胺化合物的制造方法 |
| KR20220136460A (ko) | 2014-02-05 | 2022-10-07 | 머크 샤프 앤드 돔 엘엘씨 | Cgrp-활성 화합물에 대한 정제 제제 |
| US12168004B2 (en) | 2014-02-05 | 2024-12-17 | Merck Sharp & Dohme Llc | Treatment of migraine |
| SG10202110874TA (en) | 2016-06-07 | 2021-11-29 | Jacobio Pharmaceuticals Co Ltd | Novel heterocyclic derivatives useful as shp2 inhibitors |
| KR102317480B1 (ko) | 2017-03-23 | 2021-10-25 | 자코바이오 파마슈티칼스 컴퍼니 리미티드 | Shp2 억제제로서 유용한 신규한 헤테로환형 유도체 |
| GB201707938D0 (en) | 2017-05-17 | 2017-06-28 | Univ Sheffield | Compounds |
| US12090148B2 (en) | 2020-07-29 | 2024-09-17 | Allergan Pharmaceuticals International Limited | Treatment of migraine |
| US12383545B1 (en) | 2018-06-08 | 2025-08-12 | Allergan Pharmaceuticals International Limited | Treatment of migraine |
| US20210393623A1 (en) | 2018-09-26 | 2021-12-23 | Jacobio Pharmaceuticals Co., Ltd. | Novel Heterocyclic Derivatives Useful as SHP2 Inhibitors |
| CA3206184A1 (en) | 2020-12-22 | 2022-06-30 | Allergan Pharmaceuticals International Limited | Treatment of migraine |
| US12350259B2 (en) | 2021-09-27 | 2025-07-08 | Allergan Pharmaceuticals International Limited | Methods of treating migraine |
Family Cites Families (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CZ20003672A3 (cs) | 1998-04-10 | 2001-08-15 | G. D. Searle & Co. | Heterocyklické glycyl-beta-alaninové deriváty jako agonisté vitronektinu |
| DE19911039A1 (de) | 1999-03-12 | 2000-09-14 | Boehringer Ingelheim Pharma | Abgewandelte Aminosäureamide, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung |
| GB2355456A (en) | 1999-09-30 | 2001-04-25 | Merck & Co Inc | Novel arylhydantoin derivatives useful as alpha 1a adrenoceptor antagonists |
| DE19952147A1 (de) | 1999-10-29 | 2001-05-03 | Boehringer Ingelheim Pharma | Neue Cyclopropane, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung |
| WO2002022592A2 (en) | 2000-09-14 | 2002-03-21 | Schering Corporation | Substituted urea neuropeptide y y5 receptor antagonists |
| US6831087B2 (en) | 2001-11-09 | 2004-12-14 | Hoffmann-La Roche Inc. | Pyridine substituted isoquinoline derivatives |
| GEP20074231B (en) | 2002-06-05 | 2007-11-12 | Bristol Myers Squibb Co | Calcitonin gene related peptide receptor antagonists |
| DE10250080A1 (de) | 2002-10-25 | 2004-05-13 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Ausgewählte CGRP-Antagonisten, Verfahren zu deren Herstellung sowie deren Verwendung als Arzneimittel |
| DE10250082A1 (de) | 2002-10-25 | 2004-05-13 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Ausgewählte CGRP-Antagonisten, Verfahren zu deren Herstellung sowie deren Verwendung als Arzneimittel |
| JP2007513058A (ja) | 2003-09-08 | 2007-05-24 | 武田薬品工業株式会社 | ジペプチジルぺプチダーゼ阻害剤 |
| DE102004018795A1 (de) | 2004-04-15 | 2005-10-27 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Ausgewählte CGRP-Antagonisten, Verfahren zu deren Herstellung sowie deren Verwendung als Arzneimittel |
| DE102004018794A1 (de) * | 2004-04-15 | 2005-10-27 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Ausgewählte CGRP-Antagonisten, Verfahren zu deren Herstellung sowie deren Verwendung als Arzneimittel |
| DE102004019492A1 (de) | 2004-04-22 | 2005-11-10 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Ausgewählte CGRP-Antagonisten, Verfahren zu deren Herstellung sowie deren Verwendung als Arzneimittel |
| WO2006029153A2 (en) | 2004-09-08 | 2006-03-16 | Merck & Co., Inc. | Monocyclic anilide spirolactam cgrp receptor antagonists |
| CA2580020A1 (en) | 2004-09-09 | 2006-03-23 | Ian M. Bell | Aryl spirolactam cgrp receptor antagonists |
| EP1770091A1 (de) | 2005-09-29 | 2007-04-04 | Boehringer Ingelheim Pharma GmbH & Co. KG | CGRP-Antagonisten, Verfahren zu deren Herstellung sowie deren Verwendung als Arzneimittel |
| AU2006251624A1 (en) | 2005-05-24 | 2006-11-30 | Vertex Pharmaceuticals Incorporated | Modulators of ATP-Binding cassette transporters |
| CA2612008A1 (en) | 2005-06-29 | 2007-01-04 | Palau Pharma, S.A. | Bicyclic derivatives as p38 kinase inhibitors |
| DE102005050892A1 (de) | 2005-10-21 | 2007-04-26 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Ausgewählte CGRP-Antagonisten, Verfahren zu deren Herstellung sowie deren Verwendung als Arzneimittel |
| CA2650932C (en) | 2006-05-09 | 2013-01-22 | Merck & Co., Inc. | Substituted spirocyclic cgrp receptor antagonists |
| WO2008070014A2 (en) | 2006-12-04 | 2008-06-12 | Neurogen Corporation | Biaryl ketone-substituted piperidines |
| WO2009034029A2 (de) | 2007-09-07 | 2009-03-19 | Boehringer Ingelheim International Gmbh | 1-substituierte 4 -heterocyclylpiperidine als cgrp antagonisten |
| WO2009050234A1 (de) | 2007-10-18 | 2009-04-23 | Boehringer Ingelheim International Gmbh | Cgrp-antagonisten |
| EP2065381A1 (de) | 2007-10-18 | 2009-06-03 | Boehringer Ingelheim Pharma GmbH & Co. KG | CGRP Antagonisten |
| EP2225223B1 (de) | 2007-11-22 | 2017-01-11 | Boehringer Ingelheim International GmbH | Organische verbindungen |
| US20120149698A1 (en) | 2007-11-22 | 2012-06-14 | Boehringer Ingelheim International Gmbh | Nouvel compounds |
| EP2062889A1 (de) | 2007-11-22 | 2009-05-27 | Boehringer Ingelheim Pharma GmbH & Co. KG | Verbindungen |
-
2008
- 2008-10-16 WO PCT/EP2008/063967 patent/WO2009050234A1/de not_active Ceased
- 2008-10-16 NZ NZ585347A patent/NZ585347A/en not_active IP Right Cessation
- 2008-10-16 EA EA201000612A patent/EA201000612A1/ru unknown
- 2008-10-16 AU AU2008313733A patent/AU2008313733A1/en not_active Abandoned
- 2008-10-16 KR KR1020107010480A patent/KR20100091972A/ko not_active Withdrawn
- 2008-10-16 CN CN200880112297A patent/CN101827845A/zh active Pending
- 2008-10-16 EP EP11176974.1A patent/EP2386558B1/de active Active
- 2008-10-16 BR BRPI0817835 patent/BRPI0817835A2/pt not_active IP Right Cessation
- 2008-10-16 MX MX2010003849A patent/MX2010003849A/es active IP Right Grant
- 2008-10-16 CA CA2702503A patent/CA2702503A1/en not_active Abandoned
- 2008-10-16 EP EP08839172A patent/EP2205599B1/de active Active
- 2008-10-16 JP JP2010529384A patent/JP5366960B2/ja active Active
- 2008-10-16 US US12/682,853 patent/US8450327B2/en active Active
-
2010
- 2010-04-08 IL IL204928A patent/IL204928A0/en unknown
- 2010-04-14 EC EC2010010105A patent/ECSP10010105A/es unknown
- 2010-04-16 TN TN2010000173A patent/TN2010000173A1/fr unknown
- 2010-04-16 CO CO10044754A patent/CO6270226A2/es not_active Application Discontinuation
- 2010-04-20 MA MA32781A patent/MA31782B1/fr unknown
Also Published As
| Publication number | Publication date |
|---|---|
| MA31782B1 (fr) | 2010-10-01 |
| ECSP10010105A (es) | 2010-06-29 |
| NZ585347A (en) | 2011-09-30 |
| JP5366960B2 (ja) | 2013-12-11 |
| WO2009050234A1 (de) | 2009-04-23 |
| EP2386558B1 (de) | 2014-10-01 |
| US20110172218A1 (en) | 2011-07-14 |
| CO6270226A2 (es) | 2011-04-20 |
| EP2205599B1 (de) | 2012-06-06 |
| EP2205599A1 (de) | 2010-07-14 |
| US8450327B2 (en) | 2013-05-28 |
| JP2011500637A (ja) | 2011-01-06 |
| EA201000612A1 (ru) | 2010-10-29 |
| AU2008313733A1 (en) | 2009-04-23 |
| TN2010000173A1 (fr) | 2011-11-11 |
| CN101827845A (zh) | 2010-09-08 |
| KR20100091972A (ko) | 2010-08-19 |
| CA2702503A1 (en) | 2009-04-23 |
| MX2010003849A (es) | 2010-04-27 |
| IL204928A0 (en) | 2010-11-30 |
| EP2386558A1 (de) | 2011-11-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUS2200033I1 (hu) | CGRP receptor antagonisták | |
| HUS2200025I1 (hu) | C5AR antagonisták | |
| HRP20151108T1 (xx) | Antagonisti nogo-receptora | |
| BRPI0817835A2 (pt) | Antagonistas cgrp | |
| EP2170350A4 (en) | SUBSTITUTED IMIDAZOHETEROCYCLES | |
| ATE542825T1 (de) | Substituierte piperidino-dihydrothienopyrimidine | |
| EP2163502A4 (en) | LIFT | |
| EP2168901A4 (en) | LIFT | |
| EP2165960A4 (en) | LIFT | |
| BRPI0810926A2 (pt) | Antagonista de crig | |
| BRPI0807137A2 (pt) | Agentes antiparasitários | |
| DK2178568T3 (da) | Kontrastmidler | |
| DK2132326T3 (da) | Fremgangsmåder | |
| EP2254413A4 (en) | IMIDAZOBENZAZEPIN-CGRP receptor antagonists | |
| FI20070924A0 (fi) | Hissin valmiustila | |
| BR112012003701A2 (pt) | "novos antagonistas de quinolina-hepcidina" | |
| DK2799428T3 (da) | Glucagon-antagonister | |
| ATE533744T1 (de) | N-benzoypyrrolidin-3-ylamine als histamin-3 antagonisten | |
| DK2364185T3 (da) | Disubstituerede phthalazin-hedgehog-pathway-antagonister | |
| EP2112114A4 (en) | LIFT | |
| ATE547407T1 (de) | Alkylthiopyrimidine als crth2-antagonisten | |
| ATE550321T1 (de) | Neue bradykinin b1-antagonisten | |
| FI20070562L (fi) | Hissi | |
| ATE534628T1 (de) | Urotensin ii-rezeptorantagonisten | |
| ATE512963T1 (de) | Heterocyclen als orexinantagonisten |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE AS 5A, 6A E 7A ANUIDADES. |
|
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2343 DE 01-12-2015 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |